These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17592071)

  • 1. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
    Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
    Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
    Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
    Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis.
    Rupérez M; Lorenzo O; Blanco-Colio LM; Esteban V; Egido J; Ruiz-Ortega M
    Circulation; 2003 Sep; 108(12):1499-505. PubMed ID: 12952842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells.
    Sánchez-López E; Rodriguez-Vita J; Cartier C; Rupérez M; Esteban V; Carvajal G; Rodrígues-Díez R; Plaza JJ; Egido J; Ruiz-Ortega M
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F149-60. PubMed ID: 17989112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
    Rodrigues-Díez R; Carvajal-González G; Sánchez-López E; Rodríguez-Vita J; Rodrigues Díez R; Selgas R; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
    Pharm Res; 2008 Oct; 25(10):2447-61. PubMed ID: 18633694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.
    Rodriguez-Vita J; Ruiz-Ortega M; Rupérez M; Esteban V; Sanchez-López E; Plaza JJ; Egido J
    Circ Res; 2005 Jul; 97(2):125-34. PubMed ID: 15976312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
    Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
    Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
    Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
    Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
    Rodrigues Díez R; Rodrigues-Díez R; Lavoz C; Rayego-Mateos S; Civantos E; Rodríguez-Vita J; Mezzano S; Ortiz A; Egido J; Ruiz-Ortega M
    PLoS One; 2010 Nov; 5(11):e14145. PubMed ID: 21152444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
    Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
    Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
    Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
    PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells.
    Funakoshi Y; Ichiki T; Shimokawa H; Egashira K; Takeda K; Kaibuchi K; Takeya M; Yoshimura T; Takeshita A
    Hypertension; 2001 Jul; 38(1):100-4. PubMed ID: 11463768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M; Li Z; Sun X
    Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways.
    Iwanciw D; Rehm M; Porst M; Goppelt-Struebe M
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1782-7. PubMed ID: 12947014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.